phil giesler unilever
TRANSCRIPT
Unilever Technology Ventures
Phil GieslerManaging DirectorNovember 2006
Open Innovation in Unilever
We don’t have a monopoly on new concepts or solutions.
That is why we are open for business on Open Innovation.
We want to collaborate with the best minds to make the differences that no single firm could make alone.
We would rather work with someone who has the answer today than hold out in the hope we can eventually come up with it ourselves tomorrow.
Patrick Cescau, Group Chief Executive, Unilever 6th World Conference on Detergents, Montreux
10 October 2006
Closed InnovationInternalTechnologyBase
UnileverProduct base
Vertically integrated organisation that developed its technology in-house for its sole use
Open Innovation Other’sProducts
New Unilever Business Venture
Unilever Product base
Technology In sourcing
Out-Licensing
Technology Spin outsInternal TechnologyBase
ExternalTechnology Base
Commercialise internal and external ideas inside and outside of existing product/ channel base
What is Open Innovation to Unilever?
Technologyoptions
ConsumerInsight
Businessmodels
doable
profitable
desirable
Open Innovation: Expanding the space to innovate
The space to innovate
Technologyoptions
ConsumerInsight
Businessmodels
doable
profitable
Unilever objectives from Venturing
Unilever Technology Ventures: accesses emerging technology with the potential to help innovation and growth
Unilever Ventures: creates new businesses that take Unilever and its brands into new areas or that exploit unused Unilever technology
Langholm Capital: creates options for acquisition by taking stakes in businesses that could take UL and its brands into new areas
€250MM allocated 2002 to Fund I’s in these 3 areas €50MM of this to UTV
Organisation, reporting, decision making
Conscious at the start of lessons from Corporate VC failures:
Managing corporate venturing without sufficient VC experienceMaking investments VC’s would not have made, hoping for long-term strategic benefits
Each Venture Fund runs along lines as close as possible to external VC funds.
Decision making delegated to Fund managersFund managers targeted on value creation and delivery of VC type returns
UTV Managing Directors
Dion Madsen, B.Comm, CFA
• 6 years of direct venture experience in biotechnology with RBC Capital Partners
• Executive experience in three operating companies, Chiron, Cytovax, Cyberion
• Strong investment and operating track record
Phil Giesler, M.Sc., MBA• 1999-2005: Head of
Global Household Care R&D
• 1996-1999: Put in place the Personal Care Global IC network
• Strong Unilever relationships and strong understanding of the R&D Organization
UTV Venturing Objectives
• Access emerging technologies•Potential use in Unilever’s products
•Create medium to long term value
• Change culture to “open innovation”•Influence research and development process
• Access emerging technologies•Potential use in Unilever’s products
•Create medium to long term value
• Change culture to “open innovation”•Influence research and development process
Unilever Objectives
• Generate Strong Financial Returns
Generate strong deal flowDevelop professional operational capabilitiesGain industry respect for adding valueGenerate strong returnsExpand industry and academic networksUtilize internal expertise to gain investing edge
• Become self-sustaining
• Generate Strong Financial Returns
Generate strong deal flowDevelop professional operational capabilitiesGain industry respect for adding valueGenerate strong returnsExpand industry and academic networksUtilize internal expertise to gain investing edge
• Become self-sustaining
UTV Objectives
UTV Fund I - Approach
NanotechnologyBiotoolsPersonalised genetics
Packaging materialsWater
Focus on Materials Science and Life Sciences
Fund Investment
Study FocusAreas
Consumer understandingTargeted deliveryDiagnostic equipmentNutraceuticalsRFID
Invest &Manage
UTV evolution
2002 2004 2006 2008 2010
Investments in funds
Establish VC community presence
Build deal-flow
Own deal flow
Direct investments
Re-inforceleadership
LP Strategic engagement
Towards an independent GP
Funds from 2-3 other LP’s
Self-sustaining venture model
Fund I ($60m)
Fund II ($120m)
Fund III
LP Engagement
UTV Bulletins
Visiting Associate programmes
Open Innovation “receiver/dialogue” roles within Unilever
Advisory Board